1. Scrip
  2. >>Drug Pricing

Fresh From The White House, J&J's Gorsky Talks Policy, Drug Pricing

 
• By Joseph Haas

CEO pledges transparency and responsible pricing of J&J drugs during the company’s earnings call, while outlining its goals for US health care and tax reform. Fourth quarter performance was unspectacular, although J&J's oncology and immunology portfolios showed sales growth.

Johnson & Johnson seized the moment of the company’s full-year earnings call to get out front on the US policy debate, with CEO Alex Gorsky detailing his recent conversation with President Donald Trump, outlining the firm's priorities for health care reform and announcing a business transparency plan that includes a pledge for "responsible pricing."

Gorsky, one of several US business leaders who met with Trump Jan. 23 to discuss economic policy, gave an overview of his comments during the pharma's Jan

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Drug Pricing

More from Scrip

Switzerland Biopharma To Stay Strong Despite More Cash Going To US And China

 
• By Kevin Grogan

The sector is continuing to show resilience despite financial and market challenges.

Pipeline Watch: Thirteen Approvals And Ten Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Executives On The Move: Five CEOs, Three CFOs And Two CMOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Immunovant, Zymeworks and Cassava Sciences, among others, plus Zealand Pharma acquires chief scientific officer from Eli Lilly.